Article

AAO declares November Diabetic Eye Disease Awareness month

San Francisco-According to the American Academy of Ophthalmology (AAO), November is Diabetic Eye Disease Awareness month. People with diabetes are 25 times more likely to become blind than those who do not have the condition, according to the AAO.

San Francisco-According to the American Academy of Ophthalmology (AAO), November is Diabetic Eye Disease Awareness month. People with diabetes are 25 times more likely to become blind than those who do not have the condition, according to the AAO.

A retired New York police department detective, Anthony Sclafani, knew he had a vision problem when he could not see the red or green of the traffic lights. His Type II diabetes was what was causing the problem and thanks to laser treatment and monitoring blood sugar levels, his vision is now better than it has been for years.

"The careful control of blood sugar may prevent, and in some cases, even reverse early damage from diabetic retinopathy," says K. Bailey Freund, MD, a clinical correspondent for the academy and Sclafani's doctor. "With treatment and follow-up, we can minimize vision loss, or in some cases, restore vision to better than it was before treatment. A key factor for success is the patient's commitment to keeping his [or her] blood sugar tightly controlled through diet."

If caught early enough diabetic retinopathy can be controlled before vision loss occurs with injectable and oral medications, according to the AAO.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
Steven R. Sarkisian, Jr., MD, ABO, speaks about glaucoma at the 2025 ASCRS annual meeting
© 2025 MJH Life Sciences

All rights reserved.